ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2006
Do sulfonylurea drugs increase the risk of cardiac events?
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Glycemic control and cardiovascular disease: what's a doctor to do?Current diabetes reports · 2012Pooled it
- Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus.Mayo Clinic proceedings · 2011Pooled it
- Use of Diabetes Medications before and after a Heart Failure-Related Hospitalization among Nursing Home Residents.Journal of the American Medical Directors Association · 2024Article
- Review
- Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus.Pharmaceuticals (Basel, Switzerland) · 2021Review
- The Effect of an Aerobic Exercise Programme on Blood Glucose Level, Cardiovascular Parameters, Peripheral Oxygen Saturation, and Body Mass Index among Southern Nigerians with Type 2 Diabetes Mellitus, Undergoing Concurrent Sulfonylurea and Metformin Treatment.The Malaysian journal of medical sciences : MJMS · 2019Article
- Effect of glucose-lowering therapies on heart failure.Nature reviews. Cardiology · 2018Review
- Cardiovascular mortality and oral antidiabetic drugs: protocol for a systematic review and network meta-analysis.BMJ open · 2017Article
- Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.Trends in endocrinology and metabolism: TEM · 2017Review
- Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.BMJ (Clinical research ed.) · 2016Article
- [Pharmaceutical and insulin therapy of diabetes mellitus type 2. Update].Der Internist · 2015Review
- Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.Diabetes & vascular disease research · 2015 · on this mapReview
- Protective effects of Quercus salicina on alloxan-induced oxidative stress in HIT-T15 pancreatic β cells.Experimental and therapeutic medicine · 2013Article
- Inpatient treatment of type 2 diabetes.Deutsches Arzteblatt international · 2012Review
- Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.BMJ (Clinical research ed.) · 2009 · on this mapArticle
- Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions.Diabetologia · 2007Article
- Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.